Evidence map›Paper›PMID 35327529›Full record

ReviewBiomedicines2022

Detection of

Tsimur Hasanau, Eduard Pisarev, Olga Kisil, Naosuke Nonoguchi, Florence Le Calvez-Kelm, Maria Zvereva

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Multi-Omics Integration for Advancing Glioma Precision Medicine.Annals of clinical and translational neurology · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Prevalence ofCurrent issues in molecular biology · 2024
    Article
  19. The mutated in colorectal cancer (Frontiers in oncology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Tsimur HasanauDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Eduard PisarevFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0002-5764-3977
Olga KisilGause Institute of New Antibiotics, 119021 Moscow, Russia.ORCID 0000-0003-4799-1318
Naosuke NonoguchiDepartment of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
Florence Le Calvez-KelmGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC), 69372 Lyon, France.ORCID 0000-0003-0063-5068
Maria ZverevaChair of Chemistry of Natural Compounds, Department of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-7432-1574
Lomonosov Moscow State University · RUCentre international de recherche sur le cancer · FRGause Institute of New Antibiotics Russian Academy of Medical Sciences · RUOsaka University of Pharmaceutical Sciences · JP

Funding

World Health Organization 001
6 · The paper itself

Abstract

This article reviews the existing approaches to determining the

Indexed as

central nervous system tumorsddPCRdPCRgliomamolecular biomarkersMRINGSnoninvasive detectionSanger sequencingtelomerase activationtelomerase reverse transcriptaseTERTTERT mutationsTERT promoter region

Identifiers

PMID35327529
PMCPMC8945783
OpenAlexW4220967200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.